<H1>Chapter DOI: 10.1208/aapsj070238<br/>Cited-By Count: 4</H1><table border="1" width="30%"><tr><td>Total References</td><td>34</td></tr><tr><td>Springer references</td><td>11</td></tr><tr><td>Non Springer references</td><td>23</td></tr><tr><td>BibStructured Count</td><td width="10%">30</td></tr><tr><td>BibUnstructured Count</td><td width="10%">4</td></tr><tr><td>DOI already available in SpringerLink</td><td>23</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>2</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>2</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>2</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.<Emphasis Type="Italic">J Pharmacokinet Biopharm.</Emphasis> 1977;5:445&#8211;479.</td><td><a href=http://dx.doi.org/10.1007/BF01061728>10.1007/BF01061728</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Sheiner LB, Rosenberg B, Melmon KL. Modelling of individual pharmacolinetics for computer-aided drug dosage.<Emphasis Type="Italic">Comput Biomed Res.</Emphasis> 1972;5:411&#8211;459.</td><td><a href=http://dx.doi.org/10.1016/0010-4809(72)90051-1>10.1016/0010-4809(72)90051-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Mentre' F, Burtin P, Merle' Y, van Bree J, Mallet A, Steimer J-L. Sparse-sampling optimal designs in pharmacokinetics and toxicokinetics.<Emphasis Type="Italic">Drug Inf. J</Emphasis> 1995;29:997&#8211;1019.</td><td><a href=http://dx.doi.org/10.1177/009286159502900321>10.1177/009286159502900321</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_2, ArticleTitle, FirstPage, VolumeID, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR4</td><td>BibBook</td><td>Beal SL, Sheiner LB, eds. NONMEM Users Guides. Hanover, MD: GloboMax, LLC; 1989-1998.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Available</span> <span style='background:#DDDDDD'>at</span></span></aug>: <span style='background:#FF3300'>http://www.uq.edu.au/pharmacy/sduffull/popt.htm</span>. Accessed date: July 19, <span style='background:#66FF66'>2005</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Retout S, Duffull S, Mentre' F. Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs.<Emphasis Type="Italic">Comput Methods Programs Biomed.</Emphasis> 2001;65:141&#8211;151.</td><td><a href=http://dx.doi.org/10.1016/S0169-2607(00)00117-6>10.1016/S0169-2607(00)00117-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Retout S, Mentre' F. Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics.<Emphasis Type="Italic">J Biopharm Stat.</Emphasis> 2003;13:209&#8211;227.</td><td><a href=http://dx.doi.org/10.1081/BIP-120019267>10.1081/BIP-120019267</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Retout S, Mentre' F. Optimisation of individual and population designs using Splus.<Emphasis Type="Italic">J Pharmacokinet Pharmacodyn.</Emphasis> 2003;30:417&#8211;453.</td><td><a href=http://dx.doi.org/10.1023/B:JOPA.0000013000.59346.9a>10.1023/B:JOPA.0000013000.59346.9a</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Green B, Duffull SB. Prospective evaluation of a D-optimal designed population pharmacokinetic study.<Emphasis Type="Italic">J Pharmacokinet Pharmacodyn.</Emphasis> 2003;30:145&#8211;161.</td><td><a href=http://dx.doi.org/10.1023/A:1024467714170>10.1023/A:1024467714170</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibBook</td><td>Harrel F. Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival. New York: Springer, 2001;56&#8211;60.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Mandema JW, Verotta D, Sheiner LB. Building population pharmacokinetic-pharmacodynamic models. I. Models for covariate effects.<Emphasis Type="Italic">J Pharmacokinet Biopharm.</Emphasis> 1992;20:511&#8211;528.</td><td><a href=http://dx.doi.org/10.1007/BF01061469>10.1007/BF01061469</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Jonsson EN, Karlsson MO. Automated covariate model building with NONMEM.<Emphasis Type="Italic">Pharm. Res.</Emphasis> 1998;15:1463&#8211;1468.</td><td><a href=http://dx.doi.org/10.1023/A:1011970125687>10.1023/A:1011970125687</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Kowalski KG, Huntmacher MM. Efficient screening of covariates in population models using Wald's approximation to the likelihood ratio test.<Emphasis Type="Italic">J Pharmacokinet Pharmacodyn.</Emphasis> 2001;28:253&#8211;275.</td><td><a href=http://dx.doi.org/10.1023/A:1011579109640>10.1023/A:1011579109640</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Available</span> <span style='background:#DDDDDD'>at</span></span></aug>: <span style='background:#FF3300'>http://www.cognigencorp.com/nonmem/nm/</span> <span style='background:#FFFF0F'>99sep 152004.html. Accessed date</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR15</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Available</span> <span style='background:#DDDDDD'>at</span></span></aug>: <span style='background:#FF3300'>http://www.cognigencorp.com/nonmen/nm/</span> <span style='background:#FFFF0F'>99nov212000.html.Accessed date</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine.<Emphasis Type="Italic">Nephron.</Emphasis> 1976;16:31&#8211;42.</td><td><a href=http://dx.doi.org/10.1159/000180580>10.1159/000180580</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Girard P, Sheiner LB, Kastrissios H, Blaschke TF. Do we need full compliance data for population pharmacokinetic analysis?<Emphasis Type="Italic">J Pharmacokinet Biopharm.</Emphasis> 1996;24:265&#8211;282.</td><td><a href=http://dx.doi.org/10.1007/BF02353671>10.1007/BF02353671</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Vrijens B, Goetghebeur E. The impact of compliance in pharmacokinetic studies.<Emphasis Type="Italic">Stat Methods Med Res.</Emphasis> 1999;8:247&#8211;262.</td><td><a href=http://dx.doi.org/10.1191/096228099669221405>10.1191/096228099669221405</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Vrijens B, Goetghebeur E. Electronic monitoring of variation in drug intakes can reduce bias and improve precision in pharmacokinetic/pharmacodynamic population studies.<Emphasis Type="Italic">Stat Med.</Emphasis> 2004;23:531&#8211;544.</td><td><a href=http://dx.doi.org/10.1002/sim.1619>10.1002/sim.1619</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Lu J, Gries J-M, Verotta D, Sheiner LB. Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of noncompliance.<Emphasis Type="Italic">J Pharmacokinet Pharmacodyn.</Emphasis> 2001;28:343&#8211;362.</td><td><a href=http://dx.doi.org/10.1023/A:1011582713692>10.1023/A:1011582713692</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Mu S, Ludden TM. Estimation of population pharmacokinetic parameters in the presence of non-compliance.<Emphasis Type="Italic">J Pharmacokinet Pharmacodyn.</Emphasis>. 2003;30:53&#8211;81.</td><td><a href=http://dx.doi.org/10.1023/A:1023297426153>10.1023/A:1023297426153</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Karlsson MO, Sheiner LB. The importance of modeling interoccasion variability in population pharmacokinetic analyses.<Emphasis Type="Italic">J Pharmacokinet Biopharm.</Emphasis> 1993;21:735&#8211;750.</td><td><a href=http://dx.doi.org/10.1007/BF01113502>10.1007/BF01113502</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Wang W, Hsuan F, Chow S-C. The impact of patient compliance on drug concentration profile in multiple doses.<Emphasis Type="Italic">Stat Med.</Emphasis> 1996;15:659&#8211;669.</td><td><a href=http://dx.doi.org/10.1002/(SICI)1097-0258(19960330)15:6&lt;659::AID-SIM207&gt;3.0.CO;2-E>10.1002/(SICI)1097-0258(19960330)15:6&lt;659::AID-SIM207&gt;3.0.CO;2-E</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibBook</td><td>Kendall M, Stuart A. The Advanced Theory of Statistics, Volume 2, Inference and Relationship, Fourth Edition. New York: Macmillan, 1979:400&#8211;407.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Soy D, Beal SL, Sheiner LB. Population one-compartment pharmacokinetic analysis with missing dosage data.<Emphasis Type="Italic">Clin Pharmacol Ther.</Emphasis> 2004;76:441&#8211;451.</td><td><a href=http://dx.doi.org/10.1016/j.clpt.2004.07.010>10.1016/j.clpt.2004.07.010</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Sanathanan LP, Peck CC. The randomized concentration-controlled trial: an evaluation of its sample size efficiency.<Emphasis Type="Italic">Control Clin Trials.</Emphasis> 1991;12:780&#8211;794.</td><td><a href=http://dx.doi.org/10.1016/0197-2456(91)90041-J>10.1016/0197-2456(91)90041-J</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibChapter</td><td>Hausman JA. Instrumental variable estimation. In: Kotz, S, Johnson NI, Read CB, eds.<Emphasis Type="Italic">Encyclopedia of Statistical Sciences Volume 4</Emphasis>. New York: Wiley, 1983;150&#8211;153.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables.<Emphasis Type="Italic">Annu Rev Public Health.</Emphasis> 1998;19:17&#8211;34.</td><td><a href=http://dx.doi.org/10.1146/annurev.publhealth.19.1.17>10.1146/annurev.publhealth.19.1.17</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibChapter</td><td>Amemiya T. Two-stage least squares. In: Kotz S, Johnson NI, Read CB, eds.<Emphasis Type="Italic">Encyclopedia of Statistical Sciences Volume 9</Emphasis>. New York: Wiley, 1988;373&#8211;375.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR30</td><td>BibUnstructured</td><td><span style='background:#BDBAD6'>SAS Institute Inc. SAS/ETS Users Guide. SAS Online Doc</span>. <span style='background:#FFD9B3'>Version 8</span>. <span style='background:#66FF66'>1999</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR31</td><td>BibBook</td><td>Pearl J. Causality. Cambridge, United Kingdom: Cambridge University Press, 2000.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1017/CBO9780511803161>10.1017/CBO9780511803161</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Little RJ, Rubin DB. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches.<Emphasis Type="Italic">Annu Rev Public Health.</Emphasis> 2000;21:121&#8211;145.</td><td><a href=http://dx.doi.org/10.1146/annurev.publhealth.21.1.121>10.1146/annurev.publhealth.21.1.121</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Greenland S, Robins JM, Pearl J. Confounding and collapsibility in causal inference.<Emphasis Type="Italic">Stat Sci.</Emphasis> 1999;14:29&#8211;46.</td><td><a href=http://dx.doi.org/10.1214/ss/1009211805>10.1214/ss/1009211805</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables (with discussion).<Emphasis Type="Italic">J Am Stat Assn.</Emphasis> 1996;434:444&#8211;472.</td><td><a href=http://dx.doi.org/10.2307/2291629>10.2307/2291629</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>